- Home
- HAS vs VRNA Comparison
HAS vs VRNA Comparison
Compare HAS & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- VRNA
- Stock Information
- Founded
- HAS 1923
- VRNA 2005
- Country
- HAS United States
- VRNA United Kingdom
- Employees
- HAS N/A
- VRNA N/A
- Industry
- HAS Recreational Games/Products/Toys
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- HAS Consumer Discretionary
- VRNA Health Care
- Exchange
- HAS Nasdaq
- VRNA Nasdaq
- Market Cap
- HAS 9.6B
- VRNA 8.3B
- IPO Year
- HAS N/A
- VRNA 2017
- Fundamental
- Price
- HAS $73.82
- VRNA $94.58
- Analyst Decision
- HAS Strong Buy
- VRNA Strong Buy
- Analyst Count
- HAS 9
- VRNA 8
- Target Price
- HAS $80.22
- VRNA $105.38
- AVG Volume (30 Days)
- HAS 2.0M
- VRNA 1.2M
- Earning Date
- HAS 07-24-2025
- VRNA 08-07-2025
- Dividend Yield
- HAS 3.80%
- VRNA N/A
- EPS Growth
- HAS N/A
- VRNA N/A
- EPS
- HAS 3.03
- VRNA N/A
- Revenue
- HAS $4,265,300,000.00
- VRNA $118,535,000.00
- Revenue This Year
- HAS $3.16
- VRNA $891.79
- Revenue Next Year
- HAS $4.15
- VRNA $78.94
- P/E Ratio
- HAS $24.35
- VRNA N/A
- Revenue Growth
- HAS N/A
- VRNA N/A
- 52 Week Low
- HAS $49.00
- VRNA $14.15
- 52 Week High
- HAS $73.94
- VRNA $99.01
- Technical
- Relative Strength Index (RSI)
- HAS 69.48
- VRNA 68.57
- Support Level
- HAS $67.11
- VRNA $92.88
- Resistance Level
- HAS $73.02
- VRNA $99.01
- Average True Range (ATR)
- HAS 1.59
- VRNA 3.09
- MACD
- HAS 0.34
- VRNA -0.40
- Stochastic Oscillator
- HAS 97.81
- VRNA 69.04
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.